BiotechTube
Data
Discover
News
Company
Search...
โK
Sign in
BiotechTube
Home
/
Bright Minds Biosciences
/
Ian McDonald
IM
Ian McDonald
Chief Executive Officer & Director
Bright Minds Biosciences
Therapeutic Areas
Psychiatry
Neurology
Neuroscience
Bright Minds Biosciences Pipeline
Drug
Indication
Phase
BMB-101
Treatment-Resistant Depression (TRD)
Phase 2
BMB-202
Focal Onset Seizures / Epilepsy
Phase 1/2
Leadership Team at Bright Minds Biosciences
AK
Alan Kozikowski
Chief Scientific Officer & Co-Founder
JG
Jeremy Goodwin
Chief Operating Officer
MG
Mark G. Boshar
Chief Financial Officer
View full Bright Minds Biosciences profile